Who are Grove Biopharma's investors?

Grove Biopharma's investors include DCVC (Data Collective), DCVC Bio, InVivium Capital, Portal Innovations, DeepWork Capital.

How much funding has Grove Biopharma raised?

Grove Biopharma has disclosed $30M raised across 1 of its 2 known rounds.

Where is Grove Biopharma headquartered?

Grove Biopharma is headquartered in Chicago, US.

Grove Biopharma

Chicago, US · Founded 2020 · 30 employees on LinkedIn · 5 known investors

Find your way into Grove Biopharma

Paths you didn't know you had: your email and LinkedIn already hold routes to the Grove Biopharma team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Grove Biopharma develops Bionic Biologics, a drug discovery platform combining AI-enabled molecular design, precision polymer chemistry, and experimental biology to target protein-protein interactions that are inaccessible to conventional therapeutics. The platform creates cell-penetrant, protein-scale molecules designed to engage intracellular targets for pharmaceutical applications.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Geoffrey Duyk CEOGeoffrey Duyk holds an M.D. and Ph.D. from Case Western Reserve University and brings three decades of biotech industry experience spanning academic research (Assistant Professor at Harvard Medical School, Assistant Investigator at HHMI), drug discovery roles (VP of Genomics at Millennium Pharmaceuticals, President of R&D at Exelixis), and investment (Managing Director at TPG Biotechnology and co-founder of Circularis Partners). He is CEO of Grove Biopharma, which develops the Bionic Biologics platform for targeting intracellular protein-protein interactions in cancer and neurodegeneration.

Investors · 5

DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M

How we know: DCVC (Data Collective)'s portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

DCVC Biolisted by DCVC BioPalo Alto

How we know: DCVC Bio's portfolio page · funding news · Not right? Tell us

InVivium Capitallisted by InVivium CapitalChicago

Portal Innovationslisted by Portal InnovationsChicago

How we know: Portal Innovations's portfolio page · Not right? Tell us

DeepWork CapitalreportedOrlando

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

$30M disclosed across 1 of 2 rounds · 2025

$30MSeries AApr 2025 · 3 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Grove Biopharma do?: Grove Biopharma develops Bionic Biologics, a drug discovery platform combining AI-enabled molecular design, precision polymer chemistry, and experimental biology to target protein-protein interactions that are inaccessible to conventional therapeutics. The platform creates cell-penetrant, protein-scale molecules designed to engage intracellular targets for pharmaceutical applications.
Who are Grove Biopharma's investors?: Grove Biopharma's investors include DCVC (Data Collective), DCVC Bio, InVivium Capital, Portal Innovations, DeepWork Capital.
How much funding has Grove Biopharma raised?: Grove Biopharma has disclosed $30M raised across 1 of its 2 known rounds.
Where is Grove Biopharma headquartered?: Grove Biopharma is headquartered in Chicago, US.